DMT210 Topical Gel in the Treatment of Atopic Dermatitis

Summary

The objective of the study is to evaluate the safety and efficacy of DMT210 Gel, 5% compared to vehicle control following 28 days of twice-daily topical application to selected target lesions in male and female patients with mild to moderate atopic dermatitis (AD).

Timeline

Start

2016-10

Primary completion

2017-07-14

Completion

2017-07-14

Drugs

Indications